Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30801131 | 1.00 | IDO1 (0.50) | IDO1PNMTTAAR1RAB9ANPC1 | |
| SCHEMBL1515825 | 0.83 | DPP4 (0.57) | IDO1PNMTTAAR1RAB9ANPC1 | |
| SCHEMBL6194272 | 0.82 | PNMT (0.56) | IDO1PNMTTAAR1SMN1; SMN2MEN1 | |
| SCHEMBL7461135 | 0.82 | TDP1 (0.38) | PNMTSMN1; SMN2LMNAHTTMEN1 | |
| SCHEMBL5240860 | 0.79 | CYP1A2 (0.52) | IDO1PNMTTAAR1LMNAMEN1 | |
| SCHEMBL2318046 | 0.79 | HSP90AA1 (0.49) | PNMTRAB9ANPC1SMN1; SMN2MEN1 | |
| SCHEMBL22394576 | 0.79 | PNMT (0.42) | IDO1PNMTTAAR1SMN1; SMN2LMNA | |
| SCHEMBL2556542 | 0.79 | ALDH1A1 (0.40) | IDO1PNMTTAAR1HTTMEN1 | |
| SCHEMBL5530787 | 0.79 | ALDH1A1 (0.42) | PNMTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL13824528 | 0.79 | TAAR1 (0.45) | IDO1PNMTTAAR1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111808100-A | Indole alkaloid compound and preparation method and application thereof | 广州中医药大学(广州中医药研究院) | 2020-10-23 | — | — | CN | claimed |
| CN-107686475-A | 2,3,5 3 substituted thiophenes, derivative and its synthetic method | 湘潭大学 | 2018-02-13 | — | — | CN | claimed |
| EP-1854160-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2007-11-14 | — | — | EP | claimed |
| WO-2006085319-A2 | REDOX-ACTIVE STRUCTURES AND DEVICES UTILIZING THE SAME | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2006-08-17 | — | — | WO | claimed |
| US-20020048774-A1 | Liquid phase parallel synthesis of chemical libraries | BRISTOL-MYERS SQUIBB PHARMA RESEARCH LABS, INC. | 2002-04-25 | — | — | US | claimed |
| US-6245937-B1 | COMBINATORIAL LIBRARIES OF CHEMICAL COMPOUNDS SYNTHESIZED BY BIPHASIC SYNTHESIS UTILIZING SPECIFIED TEMPLATES | DUPONT PHARMACEUTICALS RESEARCH LABORATORIES, INC. | 2001-06-12 | — | — | US | claimed |
| US-11896593-B2 | Sulfamate derivative compounds for use in treating or alleviating a psychiatric disorder | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2024-02-13 | — | — | US | disclosed |
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| US-20230324789-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PERMANENT RESIST, METHOD FOR FORMING PERMANENT RESIST, AND METHOD FOR INSPECTING PERMANENT RESIST CURED FILM | RESONAC CORPORATION (JP) | 2023-10-12 | — | — | US | disclosed |
| WO-2023193070-A1 | PAN-CHEMOKINE ANTAGONISTS FOR USE IN TREATING CANCER AND IMMUNE DISORDERS | "MICAR INNOVATION" LTD. (BG) | 2023-10-12 | — | — | WO | disclosed |
| CN-110582726-B | Positive photosensitive resin composition, thermal crosslinking agent for positive photosensitive resin, pattern cured film, method for producing pattern cured film, semiconductor element, and electronic device | 株式会社力森诺科 | 2023-08-04 | — | — | CN | disclosed |
| EP-4211125-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER | Bio-Pharm Solutions Co., Ltd. (KR) | 2023-07-19 | — | — | EP | disclosed |
| CN-116234798-A | Sulfamate derivative compounds for the treatment or alleviation of psychotic disorders | 生物药品解决方案有限公司 | 2023-06-06 | — | — | CN | disclosed |
| US-4364952-A | Certain 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylates, composition containing same and method of use | BAYER AKTIENGESELLSCHAFT (DE) | 1982-12-21 | — | — | US | disclosed |
| US-4338467-A | IN THE PRESENCE OF A COBALT CATALYST AND A NITRILE SOLVENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-07-06 | — | — | US | disclosed |
| EP-0042093-A2 | 4-Aralkyl-1,4-dihydropyridines, processes for praparing them, their use as medicines and preparation thereof | BAYER AG (DE) | 1981-12-23 | — | — | EP | disclosed |
| EP-0034430-A1 | Process for preparing arylacetaldehydes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-08-26 | — | — | EP | disclosed |
| US-4267359-A | Novel carboxylic acid esters | ZOECON CORPORATION (US) | 1981-05-12 | — | — | US | disclosed |
| EP-0024348-A1 | Substituted 6-Phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-R trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them | MERCK & CO. INC. (US) | 1981-03-04 | — | — | EP | disclosed |
| US-4204071-A | 4-Aryl-3-butenoic acids and lower alkyl esters | ZOECON CORPORATION (US) | 1980-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020048774-A1 | Liquid phase parallel synthesis of chemical libraries | CDK2, CDC25C, POLR2H | IDO1 1450/4885PNMT 989/4885TAAR1 3279/4885 |
| US-11896593-B2 | Sulfamate derivative compounds for use in treating or alleviating a psychiatric disorder | SLC6A4, SLC6A3, SLC6A2 | IDO1 312/4885PNMT 203/4885TAAR1 379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.